205 Minimally invasive approaches in locally advanced cervical cancer patients undergoing radical surgery after chemoradiotherapy: a propensity score analysis. (13th November 2020)
- Record Type:
- Journal Article
- Title:
- 205 Minimally invasive approaches in locally advanced cervical cancer patients undergoing radical surgery after chemoradiotherapy: a propensity score analysis. (13th November 2020)
- Main Title:
- 205 Minimally invasive approaches in locally advanced cervical cancer patients undergoing radical surgery after chemoradiotherapy: a propensity score analysis
- Authors:
- Gallotta, V
Federico, A
Fanfani, F
Chiantera, V
Cosentino, F
Turco, L
Legge, F
Pedone Anchora, L
Bizzarri, N
Macchia, G
Valentini, V
Scambia, G
Ferrandina, GM - Abstract:
- Abstract : Objectives: To evaluate the oncological and surgical outcome of minimally invasive radical surgery (MI-RS) compared to open radical surgery (O-RS) in locally advanced cervical cancer (LACC) after preoperative chemoradiation (CT/RT). Methods: Data relative to stage IB2-IVA cervical cancer patients managed by CT/RT and RS were retrospectively analyzed. Results: Starting from 686 patients, the propensity score matching resulted in 462 cases (231 per group), balanced for FIGO stage, lymph node status, histotype, tumor grade and clinical response to CT/RT. Overall, 107 recurrences were registered with no difference in the pattern of recurrences between the two surgical approaches. The 5-year disease-free survival (DFS) was 73.7% in the O-RS patients, 73.0% in the MI-RS ones (HR 1.034, 95% CI: 0.708–1.512, p=0.861). The 5-year locoregional recurrence rate was 12.5% (O-RS) versus 15.2% (MI-RS) (HR 1.174, 95% CI: 0.656–2.104, p=0.588). Deaths of disease were 62; the 5-yr disease-specific survival (DSS) was 80.4% in O-RS patients, 85.3% in the MI-RS group (HR 0.731, 95% CI: 0.438–1.220, p=0.228). Estimated blood loss was lower in the MI-RS group (p<0.001), as well as length of hospital stay (p<0.001). Early postoperative complications occurred in 77 (33.3%) patients in the O-RS group, 88 (38.1%) patients in the MI-RS group (p=0.331). Fifty-six (24.2%) patients experienced late postoperative complications in the O-RS group, 61 (26.4%) in the MI-RS group (p=0.668).Abstract : Objectives: To evaluate the oncological and surgical outcome of minimally invasive radical surgery (MI-RS) compared to open radical surgery (O-RS) in locally advanced cervical cancer (LACC) after preoperative chemoradiation (CT/RT). Methods: Data relative to stage IB2-IVA cervical cancer patients managed by CT/RT and RS were retrospectively analyzed. Results: Starting from 686 patients, the propensity score matching resulted in 462 cases (231 per group), balanced for FIGO stage, lymph node status, histotype, tumor grade and clinical response to CT/RT. Overall, 107 recurrences were registered with no difference in the pattern of recurrences between the two surgical approaches. The 5-year disease-free survival (DFS) was 73.7% in the O-RS patients, 73.0% in the MI-RS ones (HR 1.034, 95% CI: 0.708–1.512, p=0.861). The 5-year locoregional recurrence rate was 12.5% (O-RS) versus 15.2% (MI-RS) (HR 1.174, 95% CI: 0.656–2.104, p=0.588). Deaths of disease were 62; the 5-yr disease-specific survival (DSS) was 80.4% in O-RS patients, 85.3% in the MI-RS group (HR 0.731, 95% CI: 0.438–1.220, p=0.228). Estimated blood loss was lower in the MI-RS group (p<0.001), as well as length of hospital stay (p<0.001). Early postoperative complications occurred in 77 (33.3%) patients in the O-RS group, 88 (38.1%) patients in the MI-RS group (p=0.331). Fifty-six (24.2%) patients experienced late postoperative complications in the O-RS group, 61 (26.4%) in the MI-RS group (p=0.668). Conclusion: MI-RS and O-RS are associated with similar rate of recurrence and death from disease in LACC patients managed by surgery after CT/RT. No difference in early and late complications were reported. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 30(2020)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 30(2020)Supplement 3
- Issue Display:
- Volume 30, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 3
- Issue Sort Value:
- 2020-0030-0003-0000
- Page Start:
- A86
- Page End:
- A87
- Publication Date:
- 2020-11-13
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2020-IGCS.176 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19786.xml